90 related articles for article (PubMed ID: 3032440)
1. Clearance of retroviremia and regression of malignancy in cats with leukemia-lymphoma during treatment with staphylococcal protein A.
Engelman RW; Good RA; Day NK
Cancer Detect Prev; 1987; 10(5-6):435-44. PubMed ID: 3032440
[TBL] [Abstract][Full Text] [Related]
2. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response.
Snyder HW; Reed DE; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084
[TBL] [Abstract][Full Text] [Related]
3. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70.
Snyder HW; Singhal MC; Hardy WD; Jones FR
J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496
[TBL] [Abstract][Full Text] [Related]
4. Biological effects of staphylococcal protein A immunotherapy in cats with induced feline leukemia virus infection.
Lafrado LJ; Mathes LE; Zack PM; Olsen RG
Am J Vet Res; 1990 Mar; 51(3):482-6. PubMed ID: 1690524
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A.
Engelman RW; Tyler RD; Trang LQ; Liu WT; Good RA; Day NK
Am J Pathol; 1985 Mar; 118(3):367-78. PubMed ID: 2983560
[TBL] [Abstract][Full Text] [Related]
6. Lymphosarcoma and persistent feline leukemia virus infection of pet cats: a system to study responses during extracorporeal treatments.
Jones FR; Grant CK; Snyder HW
J Biol Response Mod; 1984; 3(3):286-92. PubMed ID: 6086847
[TBL] [Abstract][Full Text] [Related]
7. Appearance of cytotoxic antibody to viral gp70 on feline lymphoma cells (FL-74) in cats during ex vivo immunoadsorption therapy: quantitation, characterization, and association with remission of disease and disappearance of viremia.
Liu WT; Engelman RW; Trang LQ; Hau K; Good RA; Day NK
Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3516-20. PubMed ID: 6328520
[TBL] [Abstract][Full Text] [Related]
8. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
9. Real-time PCR investigation of feline leukemia virus proviral and viral RNA loads in leukocyte subsets.
Cattori V; Pepin AC; Tandon R; Riond B; Meli ML; Willi B; Lutz H; Hofmann-Lehmann R
Vet Immunol Immunopathol; 2008 May; 123(1-2):124-8. PubMed ID: 18304650
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption.
Snyder HW; Jones FR; Day NK; Hardy WD
J Immunol; 1982 Jun; 128(6):2726-30. PubMed ID: 6281336
[TBL] [Abstract][Full Text] [Related]
11. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
12. Remission of leukemia and loss of feline leukemia virus in cats injected with Staphylococcus protein A: association with increased circulating interferon and complement-dependent cytotoxic antibody.
Liu WT; Good RA; Trang LQ; Engelman RW; Day NK
Proc Natl Acad Sci U S A; 1984 Oct; 81(20):6471-5. PubMed ID: 6208551
[TBL] [Abstract][Full Text] [Related]
13. Frequency and significance of feline leukemia virus infection in necropsied cats.
Reinacher M; Theilen G
Am J Vet Res; 1987 Jun; 48(6):939-45. PubMed ID: 3037951
[TBL] [Abstract][Full Text] [Related]
14. [Feline leukemia virus (FeLV) and FeLV-associated diseases in cats: a review].
Weijer K; UytdeHaag F; Osterhaus AD
Tijdschr Diergeneeskd; 1987 Jun; 112(12):726-37. PubMed ID: 3039686
[TBL] [Abstract][Full Text] [Related]
15. Suppression of feline bone marrow fibroblast colony-forming units by feline leukemia virus.
Wellman ML; Kociba GJ; Mathes LE; Olsen RG
Am J Vet Res; 1988 Feb; 49(2):227-30. PubMed ID: 2831764
[TBL] [Abstract][Full Text] [Related]
16. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
Lutz H; Pedersen NC; Theilen GH
Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
[TBL] [Abstract][Full Text] [Related]
17. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats.
Pepin AC; Tandon R; Cattori V; Niederer E; Riond B; Willi B; Lutz H; Hofmann-Lehmann R
Virus Res; 2007 Jul; 127(1):9-16. PubMed ID: 17434224
[TBL] [Abstract][Full Text] [Related]
18. [Paramunization of FeLV-positive cats with PIND-AVI].
Hörber D; Mayr B
Tierarztl Prax; 1991 Jun; 19(3):311-4. PubMed ID: 1653471
[TBL] [Abstract][Full Text] [Related]
19. [Clinical aspects of infection with feline leukemia virus in cats].
Theilen GH
Tierarztl Prax; 1984; 12(4):511-22. PubMed ID: 6098972
[TBL] [Abstract][Full Text] [Related]
20. Hematologic abnormalities preceding apparent recovery from feline leukemia virus infection.
Lester SJ; Searcy GP
J Am Vet Med Assoc; 1981 Mar; 178(5):471-4. PubMed ID: 6263848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
